The PrP-hFUS transgene contains a mouse prion protein promoter directing expression of a hemagglutinin-tagged human wildtype 'fused in sarcoma cDNA' sequence (HA-hFUS). Homozygous PrP-hFUS mice from founder line WT3 (PrP-hFUS-WT3) have FUS overexpression levels that result in an aggressive neurodegenerative phenotype that recapitulates many features of human amyotrophic lateral sclerosis.
Christopher E Shaw, King's College London
The PrP-hFUS transgene expresses a hemagglutinin-tagged human wildtype fused in sarcoma cDNA sequence (HA-hFUS) under the direction of the mouse prion protein (PrP) promoter. The exogenous hFUS protein expressed from the PrP-hFUS transgene has a slightly higher molecular weight than endogenous mouse FUS due to eight additional amino acids and the presence of the HA-tag. The phenotype below describes PrP-hFUS mice from founder line WT3 (PrP-hFUS-WT3).
As expected for the PrP promoter, PrP-hFUS-WT3 mice have HA-hFUS expression levels highest in the brain (cortex), spinal cord and testis; with much lower expression in other tissues. Transgenic mice express exogenous HA-hFUS, as well as endogenous mouse FUS. Compared to nontransgenic mice, the total FUS expression levels are ~1.4-fold greater in hemizygous mice, and ~1.7-fold greater in homozygous mice. Transgene expression of HA-hFUS results in significantly decreased expression of mouse FUS in all transgenic lines (endogenous FUS is downregulated ~0.86-fold in hemizygotes, and ~ 0.62-fold in homozygotes). Mice hemizygous for the PrP-hFUS transgene are viable and fertile with no evidence of significant motor phenotype or pathology. FUS overexpression levels in homozygous mice result in an aggressive neurodegenerative phenotype that recapitulates many features of human amyotrophic lateral sclerosis (ALS). Specifically, homozygous mice exhibit early onset tremor after ~4 weeks of age, followed by globular/granular cytoplasmic FUS inclusions and neuroinflammation of the spinal cord (astroglial [GFAP] and microglial [CD68] reactivity), progressive hind-limb paralysis, and eventually death by ~12 weeks of age. This FUS-ALS phenotype is dependent upon the expression level of the FUS protein, and is associated with a significant shift in FUS localization to the cytoplasm without concomitant loss of FUS from the nucleus. Of note, fluorescent labeling of HA-tagged FUS and ubiquitin in the spinal cord anterior horn reveals FUS inclusions with no ubiquitin staining. Fluorescent labeling of HA-tagged FUS and ubiquitin in the motor cortex shows skein-like cytoplasmic FUS deposits surrounded by ubiquitin; but no co-labelling of the two proteins is evident. These PrP-hFUS mice may be useful in studying neurodegenerative disorders such as ALS and frontotemporal lobar degeneration (FTLD).
The PrP-hFUS transgene was designed to have the mouse prion protein promoter sequences (from vector MoPrp.Xho) and a human wildtype fused in sarcoma cDNA sequence with N-terminal hemagglutinin-tag (HA-hFUS). The ~1.8 kbp transgene was injected into the pronucleus of C57BL/6J oocytes fertilized with Crl:CD1(ICR) sperm. Founder mice were bred to C57BL/6J mice, and a single founder line (WT3) was able to produce transgenic offspring. Transgenic males were bred with C57BL/6J females for at least three additional generations prior to sending to The Jackson Laboratory Repository. Upon arrival, transgenic mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generations to establish our colony.
|Expressed Gene||FUS, FUS RNA binding protein, human|
|Site of Expression|
|Allele Name||transgene insertion WT3, Christopher Shaw|
|Allele Type||Transgenic (Inserted expressed sequence, Humanized sequence)|
|Allele Synonym(s)||hFUS; PrP-hFUS line WT3; PrP-hFUS-WT3|
|Gene Symbol and Name||Tg(Prnp-FUS)WT3Cshw, transgene insertion WT3, Christopher Shaw|
|Promoter||Prnp, prion protein, mouse, laboratory|
|Expressed Gene||FUS, FUS RNA binding protein, human|
|Strain of Origin||(C57BL/6 x Crl:CD1(ICR))F1|
|Molecular Note||The transgene was designed to have the mouse prion protein promoter sequences (from vector MoPrp.Xho) and a human wild-type Fused in sarcoma (FUS) cDNA sequence with N-terminal hemagglutinin-tag (HA-hFUS). Three founders were established, including line WT3.|
The donating investigator maintained their colony each generation by breeding hemizygous males with wildtype (noncarrier) females from the colony or with C57BL/6J inbred females. They report no problems breeding this way. When maintaining a live colony at The Jackson Laboratory Repository, hemizygous mice may be bred with wildtype (noncarrier) mice from the colony or with C57BL/6J inbred mice (Stock No. 000664).
When using the PrP-hFUS line WT3 mouse strain in a publication, please cite the originating article(s) and include JAX stock #017916 in your Materials and Methods section.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.